


Angus Russell - Wikipedia





















 






Angus Russell

From Wikipedia, the free encyclopedia


					Jump to:					navigation, 					search



Angus Russell


Born
Angus C. Russell
(1956-01-02) 2 January 1956 (age 61)


Nationality
British


Occupation
Businessman


Years active
1977–present


Salary
$2,826,000


Title
Former chief executive of Shire plc


Term
2008–2013


Predecessor
Matthew Emmens


Successor
Flemming Ørnskov


Angus C. Russell (born 2 January 1956) is a British businessman. He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013.



Contents


1 Early life
2 Career
3 Personal life
4 References



Early life[edit]
Russell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers.[1]
Career[edit]
Russell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman.
Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [2]
On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.[3]
Personal life[edit]
His wife lives in Montreal, Quebec, Canada.[4]
References[edit]



^ "Angus C. Russell: Executive Profile". BusinessWeek. Retrieved 23 November 2012. 
^ "Angus C. Russell". Biotimeinc. Retrieved December 21, 2016. 
^ "Severn Trent's Tony Wray create ripples as he charts a path for the water industry". Reuters. 25 October 2012. Retrieved 23 November 2012. 
^ "Shire CEO Angus Russell to retire, replaced by Bayer's Flemming Ornskov". PhillyPharma. 25 October 2012. Retrieved 23 November 2012. 







This United Kingdom business–related biographical article is a stub. You can help Wikipedia by expanding it.


v
t
e









 
						Retrieved from "https://en.wikipedia.org/w/index.php?title=Angus_Russell&oldid=788298653"					
Categories: 1956 birthsLiving peopleBritish businesspeopleBritish accountantsBritish chief executivesBritish corporate directorsBritish business biography stubsHidden categories: Articles with hCardsAll stub articles 



Navigation menu


Personal tools

Not logged inTalkContributionsCreate accountLog in 



Namespaces

Article
Talk




Variants









Views

Read
Edit
View history



More







Search



 







Navigation


Main pageContentsFeatured contentCurrent eventsRandom articleDonate to WikipediaWikipedia store 



Interaction


HelpAbout WikipediaCommunity portalRecent changesContact page 



Tools


What links hereRelated changesUpload fileSpecial pagesPermanent linkPage informationWikidata itemCite this page 



Print/export


Create a bookDownload as PDFPrintable version 



Languages



Add links 





 This page was last edited on 30 June 2017, at 17:22.
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view



 

 









Angus Russell - Wikipedia





















 






Angus Russell

From Wikipedia, the free encyclopedia


					Jump to:					navigation, 					search



Angus Russell


Born
Angus C. Russell
(1956-01-02) 2 January 1956 (age 61)


Nationality
British


Occupation
Businessman


Years active
1977–present


Salary
$2,826,000


Title
Former chief executive of Shire plc


Term
2008–2013


Predecessor
Matthew Emmens


Successor
Flemming Ørnskov


Angus C. Russell (born 2 January 1956) is a British businessman. He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013.



Contents


1 Early life
2 Career
3 Personal life
4 References



Early life[edit]
Russell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers.[1]
Career[edit]
Russell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman.
Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [2]
On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.[3]
Personal life[edit]
His wife lives in Montreal, Quebec, Canada.[4]
References[edit]



^ "Angus C. Russell: Executive Profile". BusinessWeek. Retrieved 23 November 2012. 
^ "Angus C. Russell". Biotimeinc. Retrieved December 21, 2016. 
^ "Severn Trent's Tony Wray create ripples as he charts a path for the water industry". Reuters. 25 October 2012. Retrieved 23 November 2012. 
^ "Shire CEO Angus Russell to retire, replaced by Bayer's Flemming Ornskov". PhillyPharma. 25 October 2012. Retrieved 23 November 2012. 







This United Kingdom business–related biographical article is a stub. You can help Wikipedia by expanding it.


v
t
e









 
						Retrieved from "https://en.wikipedia.org/w/index.php?title=Angus_Russell&oldid=788298653"					
Categories: 1956 birthsLiving peopleBritish businesspeopleBritish accountantsBritish chief executivesBritish corporate directorsBritish business biography stubsHidden categories: Articles with hCardsAll stub articles 



Navigation menu


Personal tools

Not logged inTalkContributionsCreate accountLog in 



Namespaces

Article
Talk




Variants









Views

Read
Edit
View history



More







Search



 







Navigation


Main pageContentsFeatured contentCurrent eventsRandom articleDonate to WikipediaWikipedia store 



Interaction


HelpAbout WikipediaCommunity portalRecent changesContact page 



Tools


What links hereRelated changesUpload fileSpecial pagesPermanent linkPage informationWikidata itemCite this page 



Print/export


Create a bookDownload as PDFPrintable version 



Languages



Add links 





 This page was last edited on 30 June 2017, at 17:22.
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view



 

 









Angus Russell - Wikipedia





















 






Angus Russell

From Wikipedia, the free encyclopedia


					Jump to:					navigation, 					search



Angus Russell


Born
Angus C. Russell
(1956-01-02) 2 January 1956 (age 61)


Nationality
British


Occupation
Businessman


Years active
1977–present


Salary
$2,826,000


Title
Former chief executive of Shire plc


Term
2008–2013


Predecessor
Matthew Emmens


Successor
Flemming Ørnskov


Angus C. Russell (born 2 January 1956) is a British businessman. He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013.



Contents


1 Early life
2 Career
3 Personal life
4 References



Early life[edit]
Russell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers.[1]
Career[edit]
Russell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman.
Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [2]
On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.[3]
Personal life[edit]
His wife lives in Montreal, Quebec, Canada.[4]
References[edit]



^ "Angus C. Russell: Executive Profile". BusinessWeek. Retrieved 23 November 2012. 
^ "Angus C. Russell". Biotimeinc. Retrieved December 21, 2016. 
^ "Severn Trent's Tony Wray create ripples as he charts a path for the water industry". Reuters. 25 October 2012. Retrieved 23 November 2012. 
^ "Shire CEO Angus Russell to retire, replaced by Bayer's Flemming Ornskov". PhillyPharma. 25 October 2012. Retrieved 23 November 2012. 







This United Kingdom business–related biographical article is a stub. You can help Wikipedia by expanding it.


v
t
e









 
						Retrieved from "https://en.wikipedia.org/w/index.php?title=Angus_Russell&oldid=788298653"					
Categories: 1956 birthsLiving peopleBritish businesspeopleBritish accountantsBritish chief executivesBritish corporate directorsBritish business biography stubsHidden categories: Articles with hCardsAll stub articles 



Navigation menu


Personal tools

Not logged inTalkContributionsCreate accountLog in 



Namespaces

Article
Talk




Variants









Views

Read
Edit
View history



More







Search



 







Navigation


Main pageContentsFeatured contentCurrent eventsRandom articleDonate to WikipediaWikipedia store 



Interaction


HelpAbout WikipediaCommunity portalRecent changesContact page 



Tools


What links hereRelated changesUpload fileSpecial pagesPermanent linkPage informationWikidata itemCite this page 



Print/export


Create a bookDownload as PDFPrintable version 



Languages



Add links 





 This page was last edited on 30 June 2017, at 17:22.
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view



 

 









Angus Russell - Wikipedia





















 






Angus Russell

From Wikipedia, the free encyclopedia


					Jump to:					navigation, 					search



Angus Russell


Born
Angus C. Russell
(1956-01-02) 2 January 1956 (age 61)


Nationality
British


Occupation
Businessman


Years active
1977–present


Salary
$2,826,000


Title
Former chief executive of Shire plc


Term
2008–2013


Predecessor
Matthew Emmens


Successor
Flemming Ørnskov


Angus C. Russell (born 2 January 1956) is a British businessman. He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013.



Contents


1 Early life
2 Career
3 Personal life
4 References



Early life[edit]
Russell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers.[1]
Career[edit]
Russell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman.
Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [2]
On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.[3]
Personal life[edit]
His wife lives in Montreal, Quebec, Canada.[4]
References[edit]



^ "Angus C. Russell: Executive Profile". BusinessWeek. Retrieved 23 November 2012. 
^ "Angus C. Russell". Biotimeinc. Retrieved December 21, 2016. 
^ "Severn Trent's Tony Wray create ripples as he charts a path for the water industry". Reuters. 25 October 2012. Retrieved 23 November 2012. 
^ "Shire CEO Angus Russell to retire, replaced by Bayer's Flemming Ornskov". PhillyPharma. 25 October 2012. Retrieved 23 November 2012. 







This United Kingdom business–related biographical article is a stub. You can help Wikipedia by expanding it.


v
t
e









 
						Retrieved from "https://en.wikipedia.org/w/index.php?title=Angus_Russell&oldid=788298653"					
Categories: 1956 birthsLiving peopleBritish businesspeopleBritish accountantsBritish chief executivesBritish corporate directorsBritish business biography stubsHidden categories: Articles with hCardsAll stub articles 



Navigation menu


Personal tools

Not logged inTalkContributionsCreate accountLog in 



Namespaces

Article
Talk




Variants









Views

Read
Edit
View history



More







Search



 







Navigation


Main pageContentsFeatured contentCurrent eventsRandom articleDonate to WikipediaWikipedia store 



Interaction


HelpAbout WikipediaCommunity portalRecent changesContact page 



Tools


What links hereRelated changesUpload fileSpecial pagesPermanent linkPage informationWikidata itemCite this page 



Print/export


Create a bookDownload as PDFPrintable version 



Languages



Add links 





 This page was last edited on 30 June 2017, at 17:22.
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view



 

 









Russell S Angus - Deming, WA | Intelius



























Sign In



We found Russell S Angus in Deming, WA


Russell S Angus

                                                                           Intelius found that Russell S Angus  is  a male between 70 and 80 years old from Deming, WA.  We have connected them to
                12 addresses,
                8 phones,
                and 4 relatives or associates.
         





Also Known As

Russ  Angus
Russell A Angus


Get Report Now

Age

Russell S Angus is in his 70s

Russell Has Lived In

Deming, WA
Bellingham, WA
Maple Falls, WA

Russell's Relatives

Maryann Angus
Erianna Flores
Sean Angus
Craig Olson







Russell S Angus



Zodiac SignCancer



GenderMale



Professional Status
Treasurer at Mother Baby Center



Get Report Now










Want to know more about Russell? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Russell, or use our people search engine to find others.
Get Background Check on Russell S Angus
Get a Criminal Check on Russell S Angus
Get a Public Record Report on Russell S Angus
Get a People Search Report on Russell S Angus


Russell S Angus's Contact Information
Known Cities Lived In
Find out where Russell S Angus has lived as well as Russell S Angus's phone numbers and email addresses.




Russell S Angus Has Lived in 2 States
Washington Address for Russell S Angus


7082 R****** W** 

Deming, WA


Has Lived In

Deming, WA
Bellingham, WA


Get Full Address Report










Phone Numbers Associated with Russell S Angus

(360) ***-**** - Deming, WA 
(360) ***-**** - Deming, WA 
(360) ***-**** - Maple Falls, WA 


Get Full Phone Report



Email Addresses Associated with Russell S Angus

r**s@***.com
r**s@***.com


Get Email Report




Russell S Angus's Professional Information
Information regarding Russell S Angus's professional history.  Find out previous places Russell S Angus has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Russell S Angus Has Worked at 4 Places
Company: Mother Baby Center
               Title: Treasurer
Company: Contemporary Design Co
               Title: Sales Manager
Russell S Angus's Experience
Title: Treasurer
               Company: Mother Baby Center
Job Details
               Mother Baby Center is a not-for-profit agency providing health &amp support services for pregnant and postpartum women, their babies &amp their families. We are a proud partner agency with the United Way of Whatcom County, and Sustainable Connections' Think Local First program.  Your donations help families in need. Thank you for becoming a part of this significant effort.  If you would like to submit an event or announcement, or would prefer not to receive these messages, please send your request to: mbstore@motherbabycenter.org.
Title: Sales Manager
               Company: Contemporary Design Co
Job Details
               Company Size: Less than $1 mil - Employee Range: Less than 25
Additional Professional Information on Russell S Angus

 See Russell S Angus's LinkedIn Profile



Russell S Angus's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Russell S Angus


Russell S Angus's known Social Networks And Potential Email Matches

Find all of Russell S Angus's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Russell Angus
Username Matches

                  RussellAngus
                  AngusRussell
                  Russell.Angus
                  Angus.Russell
                  Russell_Angus
                  Angus_Russell
                  Russell-Angus
                  Angus-Russell
                  RAngus
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
R Angus







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














TXMD Angus C. Russell Insider Trades for TherapeuticsMD Inc.


































Bulletin

Tobacco stocks crushed by FDA announcement »
        

FDA unveils plan to lower cigarette nicotine content to nonaddictive level »
            




Investor Alert







London Markets Close in:



Currencies
Futures
Metals Stocks


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































TherapeuticsMD Inc.

                  NYSE American: TXMD
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

TherapeuticsMD Inc.



Market open
 --Real time quotes
Jul 28, 2017, 10:55 a.m.


TXMD

/quotes/zigman/14634168/composite


$
5.49




Change

+0.07
+1.20%

Volume
Volume 393,204
Real time quotes








/quotes/zigman/14634168/composite
Previous close

$
			5.42
		


$
				5.49
			
Change

+0.07
+1.20%





Day low
Day high
$5.46
$5.63










52 week low
52 week high

            $3.50
        

            $8.30
        


















Insider Activity


Individual




Angus C. Russell



Mr. Angus C. Russell is Chief Executive Officer & Director at Shire Plc, a Member at Association of Corporate Treasurers, and an Advisor at Celtic Pharma Management LP. He is on the Board of Directors at InterMune, Inc. and Shire Plc. He joined ICI’s Pharmaceuticals Divisions in a management accounting role and subsequently a production accounting role. He transferred to the Corporate Planning Department where he worked on several global business strategies, executed a number of M&A deals, coordinated defense work and oversaw business activities in the Americas, Middle East, Africa, India and Pakistan. Previously, he was with Coopers & Lybrand.
He was appointed Group Investor Relations Manager for ZENECA Group plc and later was appointed Group Treasurer for ZENECA Group plc with responsibility for treasury, investor relations and the group’s captive insurance company, IC Insurance. Mr. Russell was also appointed a trustee director of the ZENECA UK Pension Fund, where he served as Chairman of the Investment Committee and a member of the Audit Committee. He played a key role in the merger of Astra and Zeneca in 1998 and was subsequently appointed VP of Corporate Finance. In 1999 he was part of a small team, which negotiated the Syngenta agrochemicals merger with Novartis.
Mr. Russell joined Shire Pharmaceuticals Group plc in December 1999 as Group Finance Director responsible for finance, IS, risk management, corporate communications and investor relations, in which position he serves now. He is a non-executive director of the City of London Investment Trust plc and is a member of the Institute of Chartered Accountants in England and Wales and a fellow of The Association of Corporate Treasurers. Mr. Russell is a member of the CBI’s Economic Affairs Committee and a past chairman of the Society of International Treasurers.



Transactions


Date
Shares
Transaction
Value





08/25/2015
13,500


 
Acquisition at $5.98 per share.


80,730


05/12/2015
35,000


 
Acquisition at $6.15 per share.


215,250





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. John C. K. Milligan 
President & Director




Mr. Robert G. Finizio 
Chief Executive Officer & Director




Mr. Daniel Alan Cartwright 
Chief Financial Officer, Treasurer & VP




Dr. Brian A. Bernick 
Director & Chief Clinical Officer




Dr. C. Christine Miller 
Chief Compliance & Regulatory Officer




Mr. Dawn  Halkuff 
Chief Commercial Officer




Mr. Michael  Donegan 
Vice President-Finance




Mr. Mitchell L. Krassan 
Chief Strategy & Performance Officer




Ms. Julia  Amadio 
Chief Product Officer




Mr. David  DeLucia 
Director-Investor Relations




Mr. Marlan  Walker 
General Counsel




Mr. Tommy George Thompson 
Chairman




Mr. Nick  Segal 
Independent Director




Mr. Angus C. Russell 
Independent Director




Mr. Cooper C. Collins 
Independent Director




Mr. J. Martin Carroll 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




10:55 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
10:55aHow do I get a reverse mortgage?
10:49aWhen should you make ‘course corrections’ to your retirement plan?
10:49aJohn McCain Casts Deciding Vote to Defeat Health Bill
10:48aInvisalign maker Align stocks surge 8% after earnings blow past estimates
10:47aDow trades flat at 21,790; S&P 500 off 0.4% at 2,466
10:47aNasdaq off 0.3% at 6,359
10:46aBREAKINGDow briefly turns positive as stock market pares opening loss
10:41aJapan slaps 50% tariff on U.S. frozen beef, first such action in 14 years
10:37aPacking the Pounds Back on Pigs
10:34aBREAKINGFDA says it plans to lower nicotine in cigarettes to non-addictive levels
10:30aDollar turns lower for the week following GDP report
10:30aSet yourself up to get the most out of retirement
10:30aTesla earnings: Will Model 3 live up to the hype?
10:29aBitcoin prices rise as Ether extends recent weakness
10:27aTreasury yields dip after second-quarter GDP data
10:26aNew rule forces big car makers into big changes in how they count revenues
10:25aThese are the times you’re actually allowed to put money back into your IRA
10:24aWeekend Sip: Is this the world’s first distilled non-alcoholic spirit?
10:19aU.S. GDP speeds up to 2.6% in 2nd quarter 
10:17aTime for GOP to face reality: Everybody is going to have health insurance
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,783.43

-13.12
-0.06%





nasdaq

/quotes/zigman/12633936/realtime
6,351.83

-30.36
-0.48%





s&p 500

/quotes/zigman/3870025/realtime
2,465.93

-9.49
-0.38%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15




























































Russell, Angus C. - The Wall Street Transcript











































 





































Angus C. Russell
ANGUS C. RUSSELL, Group Finance Director of Shire Pharmaceuticals Group
Plc, joined the company in December 1999 and is responsible for Finance,
IT and Corporate Communications. Mr. Russell served his articles with
Coopers & Lybrand and qualified as a Chartered Accountant in 1979. He
joined ICI’s Pharmaceuticals Division in 1980 in a management accounting
role and subsequently a production accounting role. In 1985 he moved to
ICI’s Petrochemicals and Plastics Division, firstly in a business
accounting role, subsequently transferring to a senior product marketing
position in 1986. In 1988, he moved to ICI’s Treasury Department in
London, where he was responsible for group long-term funding and
corporate financing activities in the Middle East and Africa. In March
1990 he transferred to the Corporate Planning Department where he worked
on several global business strategies, executed a number of M & A deals,
coordinated defense work and oversaw business activities in the
Americas, Middle East, Africa, India and Pakistan. Mr. Russell was
assigned to work on group restructuring during 1991 and subsequently
became a member of the team which planned and executed the ICI de-merger
and Zeneca flotation. On February 25 1993, he was appointed to the
position of Group Investor Relations Manager for ZENECA Group Plc. On
January 1, 1995, he was appointed Group Treasurer for ZENECA Group Plc
with responsibility for Treasury, Investor Relations, IC Insurance and
was also appointed a Trustee Director of the ZENECA UK Pension Fund. Mr.
Russell played a key role in the merger of Astra and Zeneca in 1998 and
was subsequently appointed VP of Corporate Finance. In 1999 he was part
of a small team which negotiated the Syngata agrochemicals merger with
Novartis.
Related Interviews:Angus  Russell - Shire Pharmaceuticals Group Plc (shpgy)May 22, 2001







CartLatest NewsAll American USC Footbal Player Joseph M. Boskovich Jr. Now Picks All American Value Stocks for his ClientsPaul Hogan Picks Tech Dividend Growers Microchip Technology (NASDAQ:MCHP), Xilinx (NASDAQ:XLNX) and Versum Materials (NYSE:VSM)600 Gallons of Water to Produce a McDonalds (NYSE:MCD) Quarter Pounder:  How Will Investors Profit?The Wall Street Transcript is a completely unique resource for investors and business researchers.Over 20,000 CEO, Equity Analyst and Money Manager InterviewsSubscribe now!Sign Up For Newsletter Weekly email with New In-Depth Interviews


Email: 



Most Popular InterviewsProtecting Assets Through a Rules-Based FundPaula R. Wieck Published July 24, 2017 in Investing StrategiesBuy ($25)Managing Risk Through Strict Quality StandardsJeffrey P. CornellMichael S. Jordan Published July 24, 2017 in Investing StrategiesCompanies covered: AAPL GOOG SAP NSRGY Buy ($25)Identifying Emerging-Market and International Stocks with a Bottom-Up ProcessRahul  Sharma Published July 24, 2017 in Investing StrategiesCompanies covered: 600690 GE ASX TSM HDFC LUKOY XOM TOT RDS/A IBULHSGFIN ARCLK Buy ($25)Most Popular ReportsInvesting Strategies Published July 24, 2017Buy ($175)Wireless Communications & Telecom Published July 14, 2017Buy ($175)Investing Strategies Published July 11, 2017Buy ($175) 






Top Company Interviews






Register for a Free Account to gain greater access to
            The Wall Street Transcript right now




CEO INTERVIEWSInterview with the President and CEO: Lumos Networks Corp. (NASDAQ:LMOS)Interview with the Corporate VP of Business Development, Strategy and Investor Relations: DSP Group, Inc. (NASDAQ:DSPG)Interview with the CEO and Director: Tactile Systems Technology, Inc. (NASDAQ:TCMD) 

SECTOR ROUNDTABLESNatural Gas Weighs Heavy On E&P Near-Term ProspectsRoundtable Forum:optimism Despite Uncertainty In For-profit EducationRoundtable Forum:a Shift In Focus To Natural Gas From Oil 

MONEY MANAGER INTERVIEWSProtecting Assets Through a Rules-Based FundManaging Risk Through Strict Quality StandardsIdentifying Emerging-Market and International Stocks with a Bottom-Up Process 

ANALYST INTERVIEWSAnalyzing the Secular Drivers Within Communications Infrastructure and TelecomSatellite Companies Benefiting from Growth in Data TrafficIncreased Focus on Content as Consumers Shift to Digital Consumption 




Subscribe Today!







                Since 1963
                © The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy  
            





https://www.twst.com/wp-admin/admin-ajax.php

Pin It on Pinterest





































Share This





Twitter





Facebook





Google+





Gmail





LinkedIn








































×





Join now for free!
Already a member?






First Name 





Last Name 





Email address *








Create new account
 


or create an account with a social network.

Join with Facebook


Join with Twitter


Join with Google








Username or Email address: *





Password: *






LoginJoin now! | Forgot password?
 


or login using a social network


Log in with Facebook


Log in with Twitter


Log in with Google















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Angus C. Russell - BioTime, Inc.
























































































 





Menu








Angus C. Russell










Angus C. Russell joined our Board of Directors in December 2014. Mr. Russell served as the Chief Executive Officer of Shire plc, a biopharmaceutical company, from June 2008 to April 2013. Mr. Russell served as the Chief Financial Officer of Shire from 1999 to 2008 and also served as its Principal Accounting Officer and Executive Vice President of Global Finance. Prior to joining Shire, Mr. Russell served at ICI, Zeneca and AstraZeneca for 19 years, most recently as Vice President of Corporate Finance at AstraZeneca plc. He is a Chartered Accountant, having qualified with Coopers & Lybrand (now PricewaterhouseCoopers LLP). Mr. Russell also serves as a director of Mallinckrodt plc and TherapeuticsMD, Inc., and as Chairman of the Board of Directors of Revance Therapeutics, Inc. Mr. Russell previously served as a director of Shire plc, Questcor Pharmaceuticals, Inc. until it was acquired by Mallinckrodt plc in August 2014, and InterMune, Inc. prior to its acquisition by Roche Holdings, Inc. in September 2014.
Mr. Russell brings to our Board numerous years of experience as a Chief Executive Officer of an international publicly traded specialty biopharmaceutical company and his substantial experience as an officer and director in the specialty pharmaceutical industry.
 Back 









 
CategoriesLeadership
Board of Directors
Partnerships
Scientific Publications
Glossary
Videos

Update Series
Investor & Corporate Updates
Science & Technologies




 

 
 




























Angus Russell's profile on Product Hunt




























Product HuntThe best new products, every dayAsk●|Log InSign up Angus Russell#140304@angus_russellBranch Digital99Following24FollowersFollow10 Upvotespublishthis.emailCreate a web page in seconds, by sending an email.Productivity+ 3 save 193 11WurstifyAdds beards to faces on the internetTech save 163 10CleanMyMac 3Clean, optimize, and maintain your Mac.Productivity+ 2 save 1597 48Dashlane Inbox ScanFind hidden threats like private passwords in your inboxEmail+ 2 save 468 18Blueprint by FacebookTraining and certification program for brands and marketersMarketing+ 3 save 182 2Avatar PickerUser friendly, in-page avatar changes for your web appTech save 17 0RuffleSend an anonymous picture message to anyone with a phone #Tech+ 1 save 87 9FastAdvancedGoogleSearchGoogle's advanced search operators in a Chrome ExtensionTech save 1 0#CoachellaA live feed of Instagram photos from Coachella.Tech save 7 0RuffleSend fun, anonymous picture messages to any phone numberiPhone+ 1 save 13 3Share this profile






 






Angus C. Russell, Chairman of Board of Directors, Revance Therapeutics


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Angus C. Russell



Chairman of Board of Directors
at
Revance Therapeutics


Location: Newark, CA





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Angus C. Russell



Chairman of Board of Directors
at
Revance Therapeutics


Location: Newark, CA




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Mr. Russell is a veteran in the global biopharmaceutical industry with over 30 years of experience in commercial execution, operations, and strategic acquisitions. He currently serves on the Board of Directors at InterMune, Inc. and Questcor Pharmaceuticals, Inc. and from 1999 to April, 2013, Mr. Russell served as a Director at Shire Plc. During his tenure at Shire Plc, Mr. Russell served as CEO from 2008 to 2013 and CFO from 1999 to 2008. While CEO at Shire, Mr. Russell was also the Chair of Shire’s Leadership Team and a lead member of the Shire Management Committee, which designed and implemented Shire’s immensely successful long-term business strategy.



3

Companies in Career





N/A

Related Markets





N/A

Colleagues





N/A

Related Investments








Alias
N/A



Industry
R&D in Biotech, Environmental and various industries (no marketing product yet)




Tags
N/A




Topics of Influence












Web Site







N/A



























Careers








Achievements








Investments








Related People






 Edit
View all 



Angus C. RussellCareer (3)






2014




Revance Therapeutics



Chairman of Board of Directors







1999 to Apr-2013




InterMune, Inc



Board of Directors







1999 to 2008




Shire Plc



CEO








Competencies










 Edit
View all 



Angus C. RussellEducation










Coopers & Lybrand


Chartered Accountant









 Edit



Angus C. RussellAchievements and Recognitions





Add Milestone


No milestones has been recorded for Angus C. Russell






 Edit



Angus C. RussellLinks





Add Link


No links has been recorded for Angus C. Russell









Angus C. RussellInvestments/Acquisitions





No investments has been recorded for Angus C. Russell









Angus C. RussellInvestments Representing Others





No investment reps has been recorded for Angus C. Russell








Angus C. RussellRelated People





No colleagues and peers has been recorded for Angus C. Russell








View all 



Angus C. RussellRecommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies


















